Stockreport

Pharvaris (PHVS) Is Up 5.9% After Phase 3 RAPIDe-3 Win - Has The Bull Case Changed? [Yahoo! Finance]

Pharvaris N.V. - Ordinary Shares  (PHVS) 
PDF In early December 2025, Pharvaris reported positive topline results from its RAPIDe-3 pivotal Phase 3 trial, showing that oral deucrictibant immediate-release capsules m [Read more]